Clinical Trial Update: Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing oral versus intravenous administration of esomeprazole for gastric acid suppression in peptic ulcer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Nexium (esomeprazole) (esomeprazole)

Snippet

Sponsor: Pamela Youde Nethersole Eastern Hospital | Conditions: Peptic Ulcer | Phase 4 | Status: UNKNOWN